PolyPid (PYPD) Stock Chart & Stock Price History → America’s worst nightmare? (From Porter & Company) (Ad) Free PYPD Stock Alerts $4.74 0.00 (0.00%) (As of 05/13/2024 ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial Media PolyPid Stock Price Performance5 Day Performance+5.40%1 Month Performance+3.10%3 Month Performance-23.87%6 Month Performance+17.98%Year-To-Date Performance+24.81%1 Year Performance-56.41% Receive PYPD Stock News and Ratings via Email Sign-up to receive the latest news and ratings for PolyPid and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Porter & CompanyAmerica’s worst nightmare?What This Group Has Planned for the 2024 Election Will Shock You Controversial new exposé reveals what’s really going on in America, what it means for your money, and what you must do to protect your assets before it’s too late.Click here to watch this bombshell exposé now. PYPD Stock Chart for Tuesday, May, 14, 2024 PYPD Chart by TradingView PolyPid Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/13/2024$4.74$4.74-0.06%$4.75$4.57800 shs$22.75 million05/10/2024$4.50$4.74+5.40%$4.75$4.57804 shs$22.75 million05/09/2024$4.31$4.50+4.41%$4.60$4.25995 shs$21.60 million05/08/2024$4.86$4.31-11.32%$4.90$4.207,792 shs$20.69 million05/07/2024$4.94$4.86-1.62%$4.86$4.693,990 shs$23.33 million05/06/2024$4.94$4.94$4.94$4.94208 shs$23.71 million Get the Latest News and Ratings for PYPD and Related StocksEnter your email address below to receive the latest news and analysts' ratings for PolyPid and its competitors with MarketBeat's FREE daily newsletter. 05/03/2024$4.80$4.94+2.92%$4.94$4.94897 shs$23.71 million05/02/2024$5.00$4.80-4.00%$4.98$4.802,976 shs$23.04 million05/01/2024$4.77$5.00+4.78%$5.09$4.808,730 shs$24 million04/30/2024$4.77$4.77$4.77$4.77161 shs$22.91 million04/29/2024$4.75$4.77+0.41%$4.79$4.632,874 shs$22.91 million04/26/2024$4.81$4.75-1.25%$4.90$4.752,321 shs$22.80 million04/25/2024$4.52$4.81+6.42%$4.81$4.701,523 shs$23.07 million04/24/2024$4.49$4.52+0.67%$4.59$4.52885 shs$21.70 million04/23/2024$4.43$4.49+1.47%$4.50$4.40905 shs$21.55 million04/22/2024$4.40$4.43+0.57%$4.50$4.403,559 shs$21.24 million04/19/2024$4.30$4.49+4.42%$4.50$4.321,310 shs$21.55 million04/18/2024$4.44$4.30-3.15%$4.50$4.305,248 shs$20.64 million04/17/2024$4.74$4.44-6.33%$4.44$4.441,079 shs$21.31 million04/16/2024$4.50$4.74+5.33%$4.74$4.25807 shs$22.75 million04/15/2024$4.60$4.50-2.17%$4.64$4.503,479 shs$21.60 million04/12/2024$4.50$4.60+2.22%$4.60$4.601,391 shs$22.08 million04/11/2024$4.65$4.50-3.23%$4.50$4.50460 shs$21.59 million04/10/2024$4.25$4.65+9.41%$4.65$4.252,223 shs$22.32 million04/09/2024$4.50$4.25-5.56%$4.49$4.25654 shs$20.40 million04/08/2024$4.83$4.50-6.74%$4.95$4.2021,522 shs$21.60 million04/05/2024$4.60$4.82+4.78%$4.82$4.70548 shs$23.14 million04/04/2024$4.78$4.60-3.77%$4.71$4.506,833 shs$22.08 million04/03/2024$4.80$4.78-0.35%$4.80$4.534,404 shs$22.94 million04/02/2024$4.90$4.80-2.11%$4.89$4.801,287 shs$23.02 million04/01/2024$4.60$4.90+6.52%$5.00$4.88994 shs$23.51 million03/29/2024$5.00$4.60-8.00%$5.50$4.604,573 shs$22.08 million03/28/2024$4.70$5.00+6.38%$5.50$5.004,573 shs$24 million03/27/2024$4.84$4.70-2.89%$4.70$4.701,496 shs$22.56 million03/26/2024$4.73$4.84+2.33%$4.85$4.80927 shs$8.01 million03/25/2024$4.70$4.73+0.64%$4.73$4.70147 shs$7.81 million03/22/2024$5.19$4.90-5.59%$5.17$4.703,313 shs$8.09 million03/21/2024$4.64$5.19+11.85%$5.19$4.507,621 shs$8.56 million03/20/2024$5.16$4.64-9.99%$5.17$4.642,302 shs$7.66 million03/19/2024$5.28$5.16-2.37%$5.19$5.112,973 shs$8.51 millionWhat’s Really Next for America… (Ad)Millions of Unsuspecting Americans Could be Wiped Out… Yet those who watch this bombshell exposé and prepare before it’s too late could have the chance to protect their financial future and grow their wealth significantly.Click here to stream this controversial exposé now.03/18/2024$5.49$5.28-3.83%$5.28$5.28398 shs$8.71 million03/15/2024$5.09$5.03-1.18%$5.29$5.0341 shs$8.30 million03/14/2024$5.14$5.09-0.97%$5.49$5.00307 shs$8.40 million03/13/2024$5.35$5.14-3.93%$5.31$5.141,807 shs$8.48 million03/12/2024$5.48$5.35-2.37%$5.45$5.35238 shs$8.85 million03/11/2024$5.45$5.48+0.55%$5.48$5.45604 shs$9.04 million03/08/2024$5.45$5.45$5.47$5.45674 shs$8.99 million03/07/2024$5.69$5.45-4.22%$5.50$5.45726 shs$9.01 million03/06/2024$5.42$5.69+4.98%$5.92$5.421,138 shs$9.39 million03/05/2024$5.44$5.42-0.37%$5.59$5.40661 shs$8.94 million03/04/2024$5.95$5.44-8.51%$5.73$5.352,514 shs$8.98 million03/01/2024$5.36$5.95+10.94%$5.95$5.551,393 shs$9.81 million02/29/2024$5.95$5.36-9.92%$5.78$5.332,232 shs$8.84 million02/28/2024$5.47$5.95+8.78%$6.58$5.958,188 shs$9.82 million02/27/2024$5.61$5.47-2.50%$5.80$5.471,480 shs$9.05 million02/26/2024$5.67$5.61-1.06%$5.61$5.501,410 shs$9.26 million02/23/2024$5.57$5.28-5.21%$5.75$5.283,007 shs$8.71 million02/22/2024$5.34$5.57+4.31%$5.59$5.302,597 shs$9.21 million02/21/2024$5.25$5.34+1.71%$5.75$5.342,522 shs$8.81 million02/20/2024$6.40$5.25-17.97%$6.55$5.2547,304 shs$8.66 million02/19/2024$6.40$6.40$6.43$6.401,000 shs$10.56 million02/16/2024$6.31$6.45+2.22%$6.45$6.401,013 shs$10.64 million02/15/2024$6.23$6.31+1.28%$6.34$6.31414 shs$10.41 million02/14/2024$6.79$6.23-8.25%$7.00$6.236,434 shs$10.28 million02/13/2024$6.84$6.79-0.73%$7.00$6.485,795 shs$11.20 million Related Companies: Nephros Stock Price Chart PAVmed Stock Price Chart Lyra Therapeutics Stock Price Chart Meihua International Medical Technologies Stock Price Chart Inspira Technologies Oxy B.H.N. Stock Price Chart T2 Biosystems Stock Price Chart Spectral AI Stock Price Chart NeuroOne Medical Technologies Stock Price Chart GlucoTrack Stock Price Chart Femasys Stock Price Chart Receive PYPD Stock News and Ratings via EmailSign-up to receive the latest news and ratings for PolyPid and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:PYPD) was last updated on 5/14/2024 by MarketBeat.com Staff From Our PartnersThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsBill Clinton Backing Biden Replacement???The Freeport SocietyTrump’s “Tax Free” Retirement Strategy Gold Safe ExchangeThe Crypto 9-5 Escape PlanCrypto 101 MediaExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding PolyPid Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.